Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale
Year: 2025
Type: article
Study design: Study Protocol
Source: Psychopharmacology Bulletin
DOI: 10.64719/pb.4120
Authors: Larry Alphs, MD, PhD, John Panagides, PhD, and Scott Lancaster, MS
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2993205484
